MORE►
clinical-stage
Newly appointed Visiox Pharma advisor, Vicente Anido Jr. [Courtesy]
Nanoscope Therapeutics Bolsters Board with Addition of Ophthalmic Veteran as Strategic Adviser
by Lance Murray | Mar 22, 2023
Nanoscope Therapeutics has enlisted the expertise of Vicente Anido Jr., Ph.D. to help the company advance its goal of developing sight-restoring gene therapies for retinal degenerative diseases. Anido's appointment as a strategic adviser is expected to support Nanoscope's clinical and corporate strategies, especially as the company progresses towards the potential commercialization of MCO-010.
by Quincy Preston |
Aug 25, 2020
CerSci shareholders could net another $887 million in milestones and tiered royalties. The clinical-stage startup, which launched in 2015, is developing a new generation of non-opioid meds to treat acute and chronic pain.
MORE►
by Quincy Preston |
Aug 20, 2020
OncoNano Medicine, a spinout of University of Texas Southwestern, uses pH as a biomarker to detect metastatic cancer. Its technology, which visualizes a tumor, could be a gamechanger.
MORE►
by Alex Edwards |
Jul 13, 2020
CAGE Bio—currently a resident at Johnson & Johnson Innovation—uses a proprietary platform to develop therapeutic products for dermatology, inflammation, and immunology.
MORE►
